香港中旅(00308.HK):旅遊景區春節遊客接待量按年增69% 收入增46%
香港中旅(00308.HK)公布,今年農曆新年假期期間(2024年2月10日至17日)旅遊景區業務共接待遊客約108萬人次,按可比口徑計,較2023年及2019年同期分別增長約69%及15%。期內旅遊景區業務實現收入約1.24億元人民幣,較2023年及2019年同期分別增長約46%及14%。
集團旗下港澳5家酒店於2024年農曆新年期間錄得營業收入共約1,900萬港元,較2023年同期增長約82%。期內港澳遊客量劇增,帶動集團旗下客運業務(客車及客船)總體業績向好,接待遊客量達約16.3萬人次,較2023年同期增長約123%;實現收入約2,386萬港元,增長約108%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.